Nurix Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.2M | 220k | 14.70 |
| 2023-12-31 | $515k | 50k | 10.32 |
| 2023-09-30 | $676k | 86k | 7.86 |
| 2023-06-30 | $1.5M | 153k | 9.99 |
| 2023-03-31 | $1.9M | 211k | 8.88 |
| 2022-12-31 | $2.9M | 263k | 10.98 |
| 2022-06-30 | $1.4M | 112k | 12.67 |
| 2022-03-31 | $4.2M | 299k | 14.01 |
| 2021-12-31 | $1.8M | 63k | 28.95 |
| 2021-09-30 | $1.6M | 52k | 29.95 |
| 2021-06-30 | $1.3M | 51k | 26.52 |
| 2020-12-31 | $302k | 9.2k | 32.88 |
| 2020-09-30 | $8.6M | 245k | 34.91 |